Compare VVOS & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VVOS | UGRO |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1M | 13.2M |
| IPO Year | 2020 | 2018 |
| Metric | VVOS | UGRO |
|---|---|---|
| Price | $1.31 | $19.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.25 | N/A |
| AVG Volume (30 Days) | 109.4K | ★ 10.3M |
| Earning Date | 05-14-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.07 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $15,031,000.00 | ★ $40,008,850.00 |
| Revenue This Year | $31.42 | $98.41 |
| Revenue Next Year | $49.82 | $23.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 8.91 | N/A |
| 52 Week Low | $1.09 | $0.11 |
| 52 Week High | $7.40 | $39.68 |
| Indicator | VVOS | UGRO |
|---|---|---|
| Relative Strength Index (RSI) | 50.58 | 61.93 |
| Support Level | N/A | $0.71 |
| Resistance Level | $1.50 | $39.68 |
| Average True Range (ATR) | 0.12 | 6.81 |
| MACD | 0.02 | 1.28 |
| Stochastic Oscillator | 64.38 | 44.90 |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).